Cost-Effectiveness Using Decision-Analytic Models

Slides:



Advertisements
Similar presentations
GOLD-Assembly Berlin 2008 J Mark FitzGerald.
Advertisements

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlikeLicense. Your use of this material constitutes acceptance of that license.
The Duke Stroke Policy Model (SPM) MI IS TIA ASY DTH HS Bleed.
1 Are you sure your improvements are cost-effective? Edward Broughton, PhD, MPH, PT University Research Co. April 11, 2014
Constructing a cost-effectiveness analysis for a vaccine to prevent rotavirus Roseann Dial RN N287E.
Slide Sets to accompany Blank & Tarquin, Engineering Economy, 6 th Edition, 2005 © 2005 by McGraw-Hill, New York, N.Y All Rights Reserved 18-1 Developed.
Exploring uncertainty in cost effectiveness analysis NICE International and HITAP copyright © 2013 Francis Ruiz NICE International (acknowledgements to:
Making Decisions in Health Care: Cost-effectiveness and the Value of Evidence Karl Claxton Centre for Health Economics, Department of Economics and Related.
Decision Analysis Prof. Carl Thompson
1 Value of Information Yot Teerawattananon, MD International Health Policy Program, Ministry of Public Health PhD candidate in Health Economics, University.
Decision Analysis. What is decision analysis? Based on expected utility theory Based on expected utility theory Used in conditions of uncertainty Used.
Introduction to Medical Decision Making and Decision Analysis
Accounting for Psychological Determinants of Treatment Response in Health Economic Simulation Models of Behavioural Interventions A Case Study in Type.
The role of economic modelling – a brief introduction Francis Ruiz NICE International © NICE 2014.
Introduction to decision modelling Andrew Sutton.
Economic Analysis and Management Todd Wagner, PhD.
Recommendations for Conducting Cost Effectiveness: Elements of the Reference Case Ciaran S. Phibbs, Ph.D. February 25, 2009.
A METHODOLOGY FOR MEASURING THE COST- UTILITY OF EARLY CHILDHOOD DEVELOPMENTAL INTERVENTIONS Quality of improved life opportunities (QILO)
Economic evaluation considers assessment of intervention effects in economic terms, which is often of greatest interest to fund allocators Intervention.
The Importance of Decision Analytic Modelling in Evaluating Health Care Interventions Mark Sculpher Professor of Health Economics Centre for Health Economics.
1. 2 Can Cost-effectiveness Analysis Address Vertical Equity Concerns? Mira Johri Jeffrey S Hoch Greg S Zaric Ahmed Bayoumi.
The Cost-Effectiveness and Value of Information Associated with Biologic Drugs for the Treatment of Psoriatic Arthritis Y Bravo Vergel, N Hawkins, C Asseburg,
The Use of Economic Evaluation For Decision Making: Methodological Opportunities and Challenges Mark Sculpher Karl Claxton Centre for Health Economics.
1 Presented by Donald S. Shepard, Ph.D. Schneider Institute for Health Policy Heller School, Room 122A, Mail Stop 035 Brandeis University Waltham, MA
Health care decision making Dr. Giampiero Favato presented at the University Program in Health Economics Ragusa, June 2008.
Schneider Institute for Health Policy Heller School Brandeis University September Donald S. Shepard, Ph.D. Schneider Institute for Health Policy.
Economic evaluation of outcomes: long term primary and surrogate endpoints Dr. Giampiero Favato presented at the University Program in Health Economics.
The Panel on Cost-Effectiveness in Health and Medicine Marthe Gold City University of London 30 October, 2003.
AGEC 608 Lecture 17, p. 1 AGEC 608: Lecture 17 Objective: Review the main aspects of cost- effectiveness analysis (CEA) and cost-utility analysis (CUA).
Decision Analysis as a Basis for Estimating Cost- Effectiveness: The Experience of the National Institute for Health and Clinical Excellence in the UK.
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 4 Economic Evaluation in Health Care.
Cost-effectiveness of converting non- sedating antihistamines from prescription to over-the-counter status Michael B. Nichol, Ph.D. Patrick Sullivan, Ph.D.
Conceptual Model Building: Overview Felicia Hill-Briggs, PhD, ABPP Associate Professor Departments of Medicine and Health, Behavior, and Society, Welch.
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
1 Cost-effectiveness of improving medical services in low-resource settings Edward Broughton, PhD, MPH, PT University Research Co. May 21, 2014
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
Economics of Implementation: Moving beyond Traditional CEA Mark Smith Paul Barnett VA Health Economics Resource Center.
Knowing what you get for what you pay An introduction to cost effectiveness FETP India.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 17: Economic Evaluation using Decision.
Joe Selby, MD MPH EBRI December 15, 2011 What Might Patient (Employee)- Centered Research Look Like?
Cost-Effectiveness Thresholds Professor of Health Economics
BACKGROUND Cost-effectiveness of Psychotherapy for Cluster C Personality Disorders and the Value of Information and Implementation Djøra I. Soeteman 1,2,
The Mysteries of Assessing Value For Money in HIV Service Delivery Unlocked: Principles, Group Exercises and Examples Part 2 Excel exercises: Mead Over.
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 19: Economic Evaluation using Patient-Level.
انواع ارزيابي های اقتصادي سيدرضا مجدزاده مرکز تحقيقات بهره برداری از دانش سلامت و دانشکده بهداشت دانشگاه علوم پزشکي و خدمات بهداشتي درماني تهران.
Recommendations for Conducting Cost Effectiveness: Elements of the Reference Case Ciaran S. Phibbs, Ph.D. September 14, 2011.
Costs of Neurostimulation Can We Afford The Therapy in 2020? Krishna Kumar MBBS MS FRCS(C) Member Ord. of Canada, Saskatchewan Ord. of Merit Clinical Professor.
How Can Cost Effectiveness Analysis Be Made More Relevant to U.S. Health Care? Paul G. Barnett, PhD February 29, 2012.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 23: Nov 17, 2008.
Budget Impact Analysis: Methods & Data Mark W. Smith, PhD VA HSR&D Health Economics Resource Center 795 Willow Road (152 MPD), Menlo Park, CA
The Role of Perspective in Economic Evaluation for Cancer Prevention Steven Kymes, Ph.D. Research Associate Professor of Ophthalmology And Visual Sciences.
Decision Analytic Approaches for Evidence-Based Practice M8120 Fall 2001 Suzanne Bakken, RN, DNSc, FAAN School of Nursing & Department of Medical Informatics.
Matching Analyses to Decisions: Can we Ever Make Economic Evaluations Generalisable Across Jurisdictions? Mark Sculpher Mike Drummond Centre for Health.
EBM --- Journal Reading Presenter :葉麗雯 Date : 2005/10/27.
Understanding the Differences Between Benefit-Cost Analysis and Cost-Effectiveness Analysis AEA Coffee Break Demonstration October 27, 2011.
A Cost-Effectiveness Analysis of Maternal Genotyping to Guide Treatment in Postnatal Patients.
1 Edward Broughton, PhD., MPH Director of Research and Evaluation, USAID Health Care Improvement Project, University Research Co., LLC
Economics of Complementary and Integrative Medicine: Where Do We Go From Here? Patricia M. Herman, ND, PhD, RAND Corporation IM4US Boston August 8, 2014.
Understanding Health Economics Nicola Cooper, PhD Professor of Healthcare Evaluation Research Department of Health Sciences University of Leicester
Benjamin Kearns, The University of Sheffield
Introduction Out-of-hospital cardiac arrest (OHCA) is the sudden cessation of the heart in an out of hospital setting. In the United States, the incidence.
Cost effectiveness Analysis: Valuing Health; Valuing Research!
College of Public Health and Human Sciences
Health care decision making
Discounting Future Benefits and Costs
Evidence-Based Public Health
Presentation Developed for the Academy of Managed Care Pharmacy
Introduction to Health Economics (1)
Presentation transcript:

Cost-Effectiveness Using Decision-Analytic Models Kee Chan, PhD Assistant Professor, Boston University VA Center for Health Quality, Outcomes and Economic Research (CHQOER), Edith Nourse Rogers Memorial Veterans Hospital, in Bedford, Massachusetts August 15, 2012 HERC Seminar Series

Speaker Contact Information Kee Chan, PhD VA Center for Health Quality, Outcomes and Economic Research (CHQOER) Bedford, Massachusetts Assistant Professor Department of Health Sciences Boston University Email: keechan@bu.edu

Overview This presentation will focused on the decision-making process and fundamental models used in cost-effectiveness analysis. Examples of Cost-Effectiveness Analysis Limitations and strengths will be discussed. Resources for further discussion.

Learning Objectives At the end of the presentation, you will learn the following for your own study design: the decision-making process. the framework used in decision-analytic model. the application in cost-effectiveness analysis.

Outline of Presentation Concept of “PROACTIVE” in Modeling. Structure of Decision Analysis Components of Cost-Effectiveness Analysis Research Studies Limitation and Strengths Resources

Decision Analysis “A good decision is a logical decision – one based on uncertainties, values, and preferences of a decision-maker.” Ronald Howard Professor, Stanford University

Concept of PROACTIVE PROactive Step 1: Defining the problem P: Problem R: Reframe the perspective O: Objectives of interest

Concept of PROACTIVE proACTive Step 2: What are the alternatives, consequences and trade-offs? A: Consider Alternatives. C: Model Consequences T: Identify Trade-offs.

Concept of PROACTIVE proactIVE Step 3: Integration and exploration I: Integrate evidence V: Optimize Expected Value E: Evaluate Uncertainty.

PROACTIVE P: Problem R: Reframe O: Objectives A: Alternatives Concept of PROACTIVE PROACTIVE P: Problem R: Reframe O: Objectives A: Alternatives C: Consequences T: Trade-offs I: Integrate V: Value E: Evaluate

Structure of Decision Analysis A Decision Tree A visual representation of all the possible options and the consequence that may follow each option.

Decision Analysis Tree Structure of Decision Analysis Decision Analysis Tree Step 1: PROactive Step 2: proACTive Step 3: proactIVE Chance node live Cost per Health Benefit Treatment A die Cost per Health Benefit live Cost per Health Benefit Treatment B die Cost per Health Benefit Decision node No Treatment Cost per Health Benefit Terminal node

Components of CEA Cost-Effectiveness Using decision-analytic models to consider the economics costs of health care. Health resources are consumed in order to produce health benefits.

Components of CEA Research Questions What is the most efficient use of this health resources, given the alternative uses? Time Resources Cost

Components of CEA Time-effectiveness An hour of a physician’s time spent with one patient is unavailable for another patient.

Resource-effectiveness Components of CEA Resource-effectiveness Health resources are consumed in order to produce health benefits. Resources used for one program cannot be spent to increase the program use of another or invest in new program.

Cost-Effectiveness Graph Components of CEA Cost-Effectiveness Graph Effect + ? Superior Trade-Off - + Costs Trade-Off inferior -

Cost-effectiveness Common measure of costs & health effectiveness. Components of CEA Cost-effectiveness Common measure of costs & health effectiveness. Measure can be expressed as Cost Case of disease prevented Lives saved Years of life saved Quality adjusted life year

Perspective A range of decision-makers confront these decisions. Components of CEA Perspective A range of decision-makers confront these decisions. Societal perspective Patient Provider Organizational

Different Types of Cost Components of CEA Different Types of Cost Total Resource Use includes different types of cost Health care resource Nonhealth care resource

Cost Calculation Laying out the cost Components of CEA Cost Calculation Laying out the cost Categorize the cost in term health vs. non-health cost Organize the sequence of event Initial cost Induced cost Adverted cost Consider short or long-run resource cost

Probabilities Probability is the chance of the event. Components of CEA Probabilities Probability is the chance of the event. Range in 0 to 1.0 0 = event is impossible 1 = event is certain 0.5 = the event is equally as likely to occur as not to occur

Components of CEA Preferences Preference-based measures reflect the values an individual has for a particular health states or the relative desirability of health outcome.

Effectiveness Health benefits in CEA can be expressed as Components of CEA Effectiveness Health benefits in CEA can be expressed as Single measure of health outcome Number of Cases Prevented Number of Cases of Cancer Detected Number of Hospital Days Reduced Combined measures Quality Adjusted Life Years (QALYs)

Using cost-effectiveness analysis Components of CEA Using cost-effectiveness analysis Cost-effectiveness using decision-analytic modeling summarize large amount of information. clarify the decision-making process. compare the different scenarios in complex system.

Incremental Cost-effectiveness ratio (ICER) Components of CEA Incremental Cost-effectiveness ratio (ICER) Incremental cost-effectiveness ratio (ICER) costs to benefits and is expressed as $ per life saved or the cost per QALY saved. - Cost intervention A Cost intervention B Effectiveness intervention A Effectiveness intervention B

Decision Analysis Tree Components of CEA Decision Analysis Tree Chance node live $400K/10 life years 0.9 Treatment A die $200K/0 life years 0.1 live $100K/8 life years 0.8 Treatment B Decision node die $50K/0 life years 0.2 No Treatment $0K/0 life years Terminal node

Incremental Cost-Effectiveness Ratio (ICER) Components of CEA Incremental Cost-Effectiveness Ratio (ICER) Question: Is the extra health benefit worth the extra cost? - $400K intervention A $100K intervention B 10 life years intervention A 8 life years intervention B ICER = $300 K per 2 life years = $150K / life year Answer: If intervention A is chosen, the additional investment of $150K results in one additional life year, relative to Intervention B.

Components of CEA Handling Uncertainty Parameter and Model structure uncertainty addressed using sensitivity analyses. One-Way Two-Way Multi-way Probabilistic

Components of CEA Examples

Cost-effectiveness Studies Registry Compare Research Studies Cost-effectiveness Studies Registry https://research.tufts-nemc.org/cear4/

Limitations Availability of Data Modeling vs. Real-time Experiment Limitations & Strengths Limitations Availability of Data Modeling vs. Real-time Experiment Assumption Uncertainty

Strengths Illustrate a Visual Aid. Formulate Objective. Limitations & Strengths Strengths Illustrate a Visual Aid. Formulate Objective. Evaluate Complex System. Inform Policy and Guidelines. Guide Research.

References and Resources Cost-effectiveness in Health and Medicine, Gold, Siegel, Russell, and Weinstein, eds. (1996), New York: Oxford Univ. Press. Decision Making in Health and Medicine, Hunink, and Glasziou (2001), Cambridge University. Decision Modelling for Health Economic Evaluation, Briggs, Claxton, and Sculpher (2007), Oxford Univ. Press. Designing and Conducting Cost-Effectiveness Analyses in Medicine and Health Care, 2nd Ed., Muennig. (2007), New York: Oxford Univ. Press. Software: TreeAge

HERC resources http://www.herc.research.va.gov/home/default.asp

Research Societies

Summary Use “PROACTIVE” modeling in your design. Construct a decision analysis tree. Use cost-effectiveness analysis. Compare research studies. Understand the limitations and strengths. Find resources and references.

Contact Information If you have any questions or would like to collaborate, please contact me: Kee Chan, PhD Assistant Professor Department of Health Sciences Boston University Tel: 617-358-6025 Email: keechan@bu.edu